What Is CAH Fair Value?
Cardinal Health (CAH) fair value estimate using multiple valuation models, updated daily.
As of October 14, 2026, Cardinal Health (CAH) has a composite fair value estimate of $643.55 based on four valuation models: DCF (47% weight), Graham Number (0% weight), PEG (33% weight), and DDM (20% weight). The current market price is $239.72, suggesting the stock is undervalued by 168.5%.
Data as of October 14, 2026 (today)
Composite Fair Value
Undervalued3 of 4 models$643.55
vs. current price of $239.72(+168.5%)
How Is CAH Fair Value Calculated?
Four independent models estimate what CAH is worth. Each uses different inputs and assumptions. The composite blends them by weight.
CAH Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
47% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$990.87
+313.3%Undervalued
Inputs used
DDM (Dividend Discount Model)
20% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$218.89
-8.7%Fair Value
Inputs used
CAH Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
0% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
N/A
Requires positive EPS and book value. Cardinal Health currently has negative earnings, so the Graham formula cannot be applied.
Inputs used
PEG (Price/Earnings to Growth)
33% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$167.30
-30.2%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $239.72 is 313.3% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $5.39B | $5.04B |
| Year 2 | $6.10B | $5.35B |
| Year 3 | $6.91B | $5.68B |
| Year 4 | $7.84B | $6.03B |
| Year 5 | $8.88B | $6.40B |
| Year 6 | $10.06B | $6.80B |
| Year 7 | $11.40B | $7.22B |
| Year 8 | $12.92B | $7.66B |
| Year 9 | $14.64B | $8.13B |
| Year 10 | $16.59B | $8.63B |
| Terminal Value | $399.97B | $208.12B |
What Are CAH's Key Financial Metrics?
Earnings & Growth
Current Price
$239.72
EPS (TTM)
$7.21
Forward P/E
17.1
Profit Margin
0.7%
Cash & Balance Sheet
Free Cash Flow
4.8B
EBITDA
4.2B
Book Value
-$12.37
Total Debt
10B
What Do Analysts Say About CAH?
Low
$235.00
Average
$270.47
High
$292.00
Upside
+12.8%
CAH Fair Value FAQ
What is the fair value of CAH?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CAH's estimated fair value is $643.55. The stock is currently trading at $239.72, which makes it undervalued by our analysis.
How is CAH's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is CAH overvalued or undervalued?
Based on our analysis, CAH is undervalued. The current price of $239.72 is 168.5% below our estimated fair value of $643.55.
What do Wall Street analysts say about CAH?
15 analysts cover Cardinal Health with a consensus rating of "Buy." The average price target is $270.47, ranging from $235.00 to $292.00. This implies 12.8% upside from the current price.